ARCT should be sold. If you look at the last month's statistics and compare it with the recent ones you can easily guess as to why it should be sod.
This is a definite buy
Arcturus Therapeutics has been doing great, which can be seen in the way its stock has been behaving. Considering that analysts are in agreement that the company's stock will go up by a minimum of 50 percent in the next twelve months, I don't see a... — read more